Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Short-Term-Debt" stands at 6.39 Billion United States Dollars as of 09/30/2025.
As of the end of Johnson & Johnson's third quarter, the item "Short Term Debt" stands at 6.39 Billion USD. This represents a decrease of -44.59 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 43.14 percent compared to the value the year prior.
The 1 year change in percent is 43.14.
The 3 year change in percent is 44.37.
The 5 year change in percent is 25.78.
The 10 year change in percent is 12.51.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Short Term Debt | 905,699,262,464.00 |
![]() | AbbVie Inc - Short Term Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Short Term Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Short Term Debt | 280,205,508,085.11 |
![]() | Novartis AG - Short Term Debt | 255,096,620,580.91 |